{"component": "definition", "props": {"groups": [{"samples": [{"hash": "lHS6d8t7Lai", "uri": "/contracts/lHS6d8t7Lai#dara", "label": "Stock Purchase and Loan Agreement", "score": 31.340862423, "published": true}, {"hash": "6LSCsLFtuVx", "uri": "/contracts/6LSCsLFtuVx#dara", "label": "Stock Purchase Agreement", "score": 31.340862423, "published": true}, {"hash": "aOmIR36zyXu", "uri": "/contracts/aOmIR36zyXu#dara", "label": "Stock Purchase Agreement (Surgivision Inc)", "score": 21.4791238877, "published": true}], "snippet": "has the meaning set forth in the preface above.", "snippet_links": [], "size": 6, "hash": "3ceb375fef8fcf47bfd5c17aff78731e", "id": 1}, {"samples": [{"hash": "h3VSaedreJp", "uri": "/contracts/h3VSaedreJp#dara", "label": "Contingent Value Rights Agreement (Ligand Pharmaceuticals Inc)", "score": 21.0, "published": true}, {"hash": "9MX6LUqDO4V", "uri": "/contracts/9MX6LUqDO4V#dara", "label": "Contingent Value Rights Agreement (Ligand Pharmaceuticals Inc)", "score": 21.0, "published": true}, {"hash": "5Ak92C41Y8C", "uri": "/contracts/5Ak92C41Y8C#dara", "label": "Contingent Value Rights Agreement (Pharmacopeia Inc)", "score": 21.0, "published": true}], "snippet": "means any product candidate from Target\u2019s dual-acting angiotensin and endothelin receptor antagonist program (including Target\u2019s Phase 2 product candidate identified by code PS433540), including related back-up compounds, research data, Intellectual Property and any other related rights or assets.", "snippet_links": [{"key": "product-candidate", "type": "definition", "offset": [10, 27]}, {"key": "phase-2", "type": "clause", "offset": [129, 136]}, {"key": "research-data", "type": "clause", "offset": [222, 235]}, {"key": "intellectual-property", "type": "clause", "offset": [237, 258]}, {"key": "related-rights", "type": "definition", "offset": [273, 287]}], "size": 3, "hash": "031c8fbdda3a817e59d1421d78dc5615", "id": 2}, {"samples": [{"hash": "3ehtPnSeGCW", "uri": "/contracts/3ehtPnSeGCW#dara", "label": "Investor Rights Agreement (Mri Interventions, Inc.)", "score": 22.9876796715, "published": true}, {"hash": "fokPdFUNEYe", "uri": "/contracts/fokPdFUNEYe#dara", "label": "Stockholder Agreement (Surgivision Inc)", "score": 21.4791238877, "published": true}, {"hash": "dnzd3ieGGHU", "uri": "/contracts/dnzd3ieGGHU#dara", "label": "Investor Rights Agreement (Surgivision Inc)", "score": 21.0, "published": true}], "snippet": "has the meaning set forth in the preface.", "snippet_links": [], "size": 3, "hash": "f95169d7028ff0e77580ba3a05dc0247", "id": 3}, {"samples": [{"hash": "4l54TEkK0U5", "uri": "/contracts/4l54TEkK0U5#dara", "label": "Commercialization Agreement (Midatech Pharma PLC)", "score": 27.2833675565, "published": true}], "snippet": "has the meaning set forth in the Preamble to this Agreement. Dara shall also include its Affiliates and Co-promotion Partners, as the context may require.", "snippet_links": [{"key": "the-preamble", "type": "clause", "offset": [29, 41]}, {"key": "to-this-agreement", "type": "clause", "offset": [42, 59]}, {"key": "the-context", "type": "clause", "offset": [130, 141]}], "size": 1, "hash": "751cbcbe5988e3382ae7e6ffa15dc1c0", "id": 4}, {"samples": [{"hash": "8QJE7G3tRoP", "uri": "https://electricalswitchboards.com.au/wp-content/uploads/2020/07/Terms-and-conditions-of-trade-Dara-Switchboards.pdf", "label": "electricalswitchboards.com.au", "score": 7.2402464066, "published": false}], "snippet": "means Brown-Denarusha Pty Ltd T/A DaRa Switchboards, its successors and assigns or any person acting on behalf of and with the authority of Brown-Denarusha Pty Ltd T/A DaRa Switchboards.", "snippet_links": [{"key": "pty-ltd", "type": "clause", "offset": [22, 29]}, {"key": "successors-and-assigns", "type": "clause", "offset": [57, 79]}, {"key": "any-person", "type": "clause", "offset": [83, 93]}, {"key": "on-behalf-of", "type": "clause", "offset": [101, 113]}, {"key": "the-authority", "type": "clause", "offset": [123, 136]}], "size": 1, "hash": "15d84c38999c668f5fba23dea6fc94b2", "id": 5}, {"samples": [{"hash": "ahzaboIhaVT", "uri": "/contracts/ahzaboIhaVT#dara", "label": "License Agreement (Pharmacopeia Drug Discovery Inc)", "score": 21.0, "published": true}], "snippet": "means dual acting antagonists of the angiotensin-II receptor (AT1 receptor) and the endothelin-1 (ETA) receptor.", "snippet_links": [], "size": 1, "hash": "945e8da262f2480b9a503237fafe8e24", "id": 6}, {"samples": [{"hash": "eyZPIFIPHCJ", "uri": "/contracts/eyZPIFIPHCJ#dara", "label": "Loan Agreement", "score": 35.1178503401, "published": true}], "snippet": "means the Department of Agriculture and Rural Affairs of each Project Implementing Entity, or any successor thereto.", "snippet_links": [{"key": "department-of-agriculture", "type": "definition", "offset": [10, 35]}, {"key": "project-implementing-entity", "type": "clause", "offset": [62, 89]}], "size": 1, "hash": "cd4e553c265907891eaa1be068a5c014", "id": 7}, {"samples": [{"hash": "fRLRpFn6M3Q", "uri": "/contracts/fRLRpFn6M3Q#dara", "label": "Loan Agreement", "score": 35.5382172435, "published": true}], "snippet": "means Gansu Province\u2019s Department of Agriculture and Rural Affairs.", "snippet_links": [{"key": "department-of-agriculture", "type": "definition", "offset": [23, 48]}], "size": 1, "hash": "307e3a3e530cd9715817a01bb693ae77", "id": 8}, {"samples": [{"hash": "1NXXIbbhR7t", "uri": "/contracts/1NXXIbbhR7t#dara", "label": "Stockholders\u2019 Agreement (Surgivision Inc)", "score": 21.0, "published": true}], "snippet": "has the meaning set forth in the recitals.", "snippet_links": [{"key": "the-recitals", "type": "clause", "offset": [29, 41]}], "size": 1, "hash": "e05541a00eeb1dba3509f49353d2d7e5", "id": 9}, {"samples": [{"hash": "5LXEtDX4vfU", "uri": "/contracts/5LXEtDX4vfU#dara", "label": "Securities Purchase Agreement (Recro Pharma, Inc.)", "score": 26.5140314853, "published": true}], "snippet": "means the business and assets of Alkermes plc acquired by the Company pursuant to that certain Purchase and Sale Agreement, dated as of March 7, 2015, by and among Alkermes Pharma Ireland Limited, Daravita Limited, Eagle Holdings USA, Inc., Recro Pharma, Inc. and Recro Pharma LLC.", "snippet_links": [{"key": "business-and-assets", "type": "clause", "offset": [10, 29]}, {"key": "by-the-company", "type": "clause", "offset": [55, 69]}, {"key": "pursuant-to", "type": "definition", "offset": [70, 81]}, {"key": "purchase-and-sale-agreement", "type": "definition", "offset": [95, 122]}, {"key": "dated-as-of", "type": "definition", "offset": [124, 135]}, {"key": "eagle-holdings", "type": "definition", "offset": [215, 229]}], "size": 1, "hash": "ab86323d60976e1ba3c6db610ccafca6", "id": 10}], "next_curs": "ClESS2oVc35sYXdpbnNpZGVyY29udHJhY3Rzci0LEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiINZGFyYSMwMDAwMDAwYQyiAQJlbhgAIAA=", "definition": {"snippet": "has the meaning set forth in the preface above.", "title": "DARA", "size": 20, "id": "dara", "examples": ["You release Hamvention and <strong>DARA</strong>, its officers and volunteers, and each and all persons involved from any liability connected with the taking, recording, digitizing, or publication and use of interviews, photographs, computer images, video and/or or sound recordings.", "Images, photos and/or videos may be used to promote similar Hamvention and <strong>DARA</strong> events in the future and highlight the event and exhibit the capabilities of Hamvention and <strong>DARA</strong>.", "<strong>DARA</strong> may not assign any of its rights or obligations under this Agreement without the prior written consent of SVI.", "Any notice or other communication required or which may be given hereunder shall be in writing and shall be delivered personally, sent by facsimile transmission or overnight courier, or sent by certified, registered or express mail, postage prepaid, and shall be deemed given when delivered if sent personally, or sent by facsimile transmission or overnight courier, or, if mailed, four days after the date of mailing, as follows: If to the Company, to: <strong>DARA</strong> BioSciences, Inc.", "<strong>DARA</strong> is a corporation duly incorporated, validly existing and in good standing under the laws of the State of Delaware, with full corporate power and authority to conduct its business as now being conducted.", "SVI has no liability or obligation to pay any fees or commissions to any broker, finder or agent with respect to the Contemplated Transactions for which <strong>DARA</strong> could become liable or obligated.", "This Agreement constitutes the valid and legally binding obligation of <strong>DARA</strong>, enforceable against <strong>DARA</strong> in accordance with its terms and conditions.", "<strong>DARA</strong> has not incurred and does not intend to incur, or believe that it will incur, debts beyond its ability to pay as such debts become due.", "<strong>DARA</strong> is able, and following the Closing <strong>DARA</strong> will be able, to pay its debts (including trade debts) as they mature.", "By participating in any Hamvention or the Dayton Amateur Radio Association (<strong>DARA</strong>) event, you consent to interview(s), photography, audio recording, video recording and its/their release, publication, exhibition, or reproduction to be used for news, web casts, promotional purposes, telecasts, advertising, inclusion on websites, social media, or any other purpose by the Dayton Hamvention and <strong>DARA</strong> and its affiliates and representatives."], "related": [["raptor", "Raptor", "Raptor"], ["elan", "Elan", "Elan"], ["cbi", "CBI", "CBI"], ["epic", "EPIC", "EPIC"], ["ani", "ANI", "ANI"]], "related_snippets": [], "updated": "2025-07-06T21:58:36+00:00"}, "json": true, "cursor": ""}}